Press

IN THE NEWS

April 2025

Perfuze CEO Wayne Allen features at SmartTREK

Wayne Allen Discusses the Company, its Novel Technology and Strategies for Growth in the U.S. Market

Read more
April 2025

Pefuze announces two significant milestones...

Completion of Enrollment in Pivotal US Clinical Study & Joe Rotger as Executive VP of Sales

Read more
March 2025

FDA 510(k) Clearance for Perfuze's Zipline™...

Perfuze Receives FDA 510(k) Clearance & Secures €22M in Additional Funding

Read more
December 2023

Millipede 070 Aspiration & 2nd Gen Millipede...

FDA Clearances for Novel Neurovascular Aspiration and Access Catheters for Stroke Treatment

READ MORE
November 2023

PRESENTED POSTER - SVIN 2023

First-in-Human Experience Using Millipede 088 Aspiration Catheter in Stroke Thrombectomy

Read More
November 2023

MARRS Trial: 1st Patient Enrolled

First Stroke Patient Enrolled in the MARRS Pivotal Clinical Trial at StonyBrook

Read More
June 2023

LATE BREAKING ABSTRACT - SNIS 2023

Multi-Center Experience Using the Millipede 088 Superboare Catheter in Stroke Thrombectomy

Read More
June 2023

Perfuze Announces Appointment of New Chair of...

Hooman Hakami Named New Chair of the Board

Read More
February 2023

Millipede 088 Access Catheter

Perfuze Announces FDA Clearance and First U.S. Clinical Use of Millipede 088 Access Catheter

Read More
March 2022

Neurovascular Company Perfuze Raises €22.5M...

Series A for New Stroke Treatment. Perfuze Raises €22.5M

Read More